| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.27 | 0.08 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.25 | 0.08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.08 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |